FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.10  |  FHIR Version n/a  User: [n/a]

36893611000001103: Trajenta 5mg tablets (Pharmaram Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 17-Apr 2019. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
113155401000001118 Trajenta 5mg tablets (Pharmaram Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
113155501000001119 Trajenta 5mg tablets (Pharmaram Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Trajenta 5mg tablets (Pharmaram Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Pharmaram Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Pharmaram Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel Import - supplier (qualifier value) false Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Pharmaram Ltd) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Pharmaram Ltd) Is a Linagliptin 5mg tablets true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Pharmaram Ltd) Has active ingredient Linagliptin true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Pharmaram Ltd) Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Pharmaram Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Pharmaram Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Pharmaram Ltd) Has specific active ingredient Linagliptin true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Pharmaram Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Pharmaram Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Pharmaram Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Pharmaram Ltd) Is a Trajenta true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Trajenta 5mg tablets (Pharmaram Ltd) 28 tablet Has AMP True Trajenta 5mg tablets (Pharmaram Ltd) Inferred relationship Existential restriction modifier
Trajenta 5mg tablets (Pharmaram Ltd) 30 tablet Has AMP True Trajenta 5mg tablets (Pharmaram Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start